vTv Therapeutics Inc.
VTVT
$35.08
-$1.74-4.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 217.24% | 74.93% | 117.74% | 19.31% | 6.83% |
| Gross Profit | 1,084.49% | -76.27% | -117.74% | -19.31% | -71.62% |
| SG&A Expenses | 25.18% | 48.67% | 12.10% | -2.64% | -7.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 108.77% | 60.62% | 64.45% | 7.91% | -1.87% |
| Operating Income | 457.73% | -61.18% | -64.45% | -7.91% | -15.57% |
| Income Before Tax | 488.19% | -60.87% | -77.14% | -15.15% | -5.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 488.19% | -60.87% | -77.14% | -15.15% | -3.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -100.00% | 55.82% | 8.54% | -2.51% |
| Net Income | 573.96% | -96.42% | -81.85% | -16.72% | -4.67% |
| EBIT | 457.73% | -61.18% | -64.45% | -7.91% | -15.57% |
| EBITDA | 458.24% | -61.87% | -64.98% | -8.22% | -15.86% |
| EPS Basic | 351.43% | -4.20% | -23.17% | -13.48% | 34.15% |
| Normalized Basic EPS | 389.82% | -20.11% | -25.86% | -14.78% | 31.76% |
| EPS Diluted | 313.32% | -4.20% | -23.17% | -13.48% | 34.15% |
| Normalized Diluted EPS | 345.76% | -20.11% | -25.86% | -14.78% | 31.76% |
| Average Basic Shares Outstanding | 88.51% | 88.50% | 47.64% | 2.87% | 58.95% |
| Average Diluted Shares Outstanding | 122.31% | 88.50% | 47.64% | 2.87% | 58.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |